Gevorg Tamamyan։ We Are Looking for Champions Around the World
Phase 3 BATTMAN Trial Launches BOT/BAL in MSS or pMMR Metastatic Colorectal Cancer
OncoDaily Grand Rounds at ASCO 2026: Sarcoma Edition
Dr. Richard Goldberg on Why FDA Must Keep Pace as CRC Rises in Younger Adults
Waleed Arafat: Final Days to Submit Abstracts for ISCO 2026
immunosarc II Trial: Sunitinib + Nivolumab in Advanced Clear Cell Sarcoma
2 New ES-SCLC Treatments Backed by EMA: A Major Shift in Care
Pavankumar Anné: Excited to be joining OncoDaily for the upcoming ZS AI in Oncology session during ASCO
Identify low-risk febrile neutropenia patients using the MASCC (Multinational Association for Supportive Care in Cancer) risk index.
Check if YES (0 points), leave unchecked if NO (+5 points)
Check if YES (0 points), leave unchecked if NO (+4 points)
Check if YES (0 points), leave unchecked if NO (+3 points)
Check if YES (+3 points), leave unchecked if NO (0 points)
Check if YES (+2 points), leave unchecked if NO (0 points)
MASCC Risk Index Scoring:
Risk Classification:
